Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $43.9400 (-2.12%) ($43.9400 - $43.9400) on Mon. Apr. 12, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.59% (three month average) | RSI | 35 | Latest Price | $43.9400(-2.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -1.7% a day on average for past five trading days. | Weekly Trend | TGTX declines -1.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(67%) ARKG(63%) ARKK(58%) IBB(58%) IWO(58%) | Factors Impacting TGTX price | TGTX will decline at least -1.795% in a week (0% probabilities). VIXM(-42%) VXX(-35%) UUP(-17%) IGOV(-4%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.795% (StdDev 3.59%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $38.96(-11.33%) | Resistance Level | $46.79 | 5 Day Moving Average | $45.69(-3.83%) | 10 Day Moving Average | $46.2(-4.89%) | 20 Day Moving Average | $46.79(-6.09%) | To recent high | -18.9% | To recent low | 5.4% | Market Cap | $5.565b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |